MedTrace Logo

Ion Channel Genetic Biomarkers: Diagnostic Capabilities in the Assessment of Bipolar Disorder

NCT03572426 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 164

Last updated 2019-07-10

No results posted yet for this study

Summary

Genotype 164 adults to evaluate six selected single nucleotide polymorphisms (SNPs) (rs1006737, rs10994336, rs10994133, rs2238071, rs1051375, rs1024582) for use as a genetic biomarker to differentiate between bipolar depression and unipolar depression.

Conditions

Interventions

OTHER

genotyping all subjects

genotyping using SNaPshot genotyping method.

Sponsors & Collaborators

  • Sigma Theta Tau

    collaborator UNKNOWN

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Kristiana Avery, PhD-c · University of Colorado, Denver

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-13
Primary Completion
2019-04-04
Completion
2019-04-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03572426 on ClinicalTrials.gov